Published in J Neuroinflammation on February 10, 2017
LPS/TLR4 signal transduction pathway. Cytokine (2008) 6.60
Activation of human dendritic cells through CD40 cross-linking. J Exp Med (1994) 6.16
Toll-like receptor signaling pathways. Science (2003) 5.86
Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev (2009) 3.56
Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol (1996) 3.56
CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med (1993) 3.11
Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol (1997) 2.62
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1996) 2.38
CD40 is functionally expressed on human thymic epithelial cells. J Immunol (1992) 2.29
Oxidative stress as a regulator of gene expression in the vasculature. Circ Res (1999) 2.26
Expression of functional CD40 by vascular endothelial cells. J Exp Med (1995) 2.16
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nat Neurosci (2002) 1.97
Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A (1990) 1.87
An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res (1992) 1.87
The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med (2001) 1.86
The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem (1991) 1.79
Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol (1994) 1.72
LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood (2005) 1.70
Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal (2006) 1.67
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke (2003) 1.61
Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke (1996) 1.59
Reduction of cPLA2alpha overexpression: an efficient anti-inflammatory therapy for collagen-induced arthritis. Eur J Immunol (2008) 1.54
Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem (2000) 1.45
Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J Biol Chem (1998) 1.39
Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem (2005) 1.33
Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci U S A (1993) 1.33
Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest (1997) 1.32
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet (2010) 1.32
The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem J (1994) 1.22
Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest (1999) 1.22
Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol (1998) 1.22
Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages. J Biol Chem (2002) 1.21
Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J Immunol (1990) 1.18
CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J Immunol (2006) 1.17
CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol (2002) 1.11
Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox). J Biol Chem (2002) 1.11
Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis (1996) 1.08
Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J Cell Biol (2003) 1.05
Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int (2002) 1.05
CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell Mol Immunol (2006) 1.05
The CD40/CD40L system: a new therapeutic target for disease. Immunol Lett (2013) 0.96
Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia (1999) 0.95
Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis Rheum (1999) 0.94
CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J Mol Med (Berl) (1997) 0.93
Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12). Eur J Immunol (2002) 0.93
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener (2011) 0.92
Role of CD40-CD40-ligand interaction in Ig-isotype switching. Curr Opin Immunol (1993) 0.91
CD40-CD40L interactions in atherosclerosis. Immunol Today (1997) 0.90
Functional CD40 antigen on B cells, dendritic cells and fibroblasts. Adv Exp Med Biol (1995) 0.90
CD40-CD40 ligand interactions in human microglia induce CXCL8 (interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-kappaB (NFkappaB) and activator protein-1 (AP-1). J Neurosci Res (2008) 0.89
The role of superoxide radical in TNF-alpha induced NF-kappaB activation. Ann Clin Lab Sci (1999) 0.86
The synergistic anti-inflammatory effects of lycopene, lutein, β-carotene, and carnosic acid combinations via redox-based inhibition of NF-κB signaling. Free Radic Biol Med (2012) 0.86
Interleukin-4 inhibits the gene expression and biosyntheis of cytosolic phospholipase A2 in lipopolysaccharide stimulated U937 macrophage cell line and freshly prepared adherent rheumatoid synovial cells. Biochem Biophys Res Commun (1997) 0.83
Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease. Neurosci Lett (2008) 0.83
Impact of the CD40-CD40L dyad in Alzheimer's disease. CNS Neurol Disord Drug Targets (2010) 0.82
Cytosolic phospholipase A2alpha is targeted to the p47phox-PX domain of the assembled NADPH oxidase via a novel binding site in its C2 domain. J Biol Chem (2008) 0.82
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway. J Neuroinflammation (2015) 0.80
The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration. J Neurochem (2015) 0.78
Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation (2016) 0.77